Drug Type Small molecule drug |
Synonyms TQA 3605, TQA-3605, TQA3605 |
Target |
Action inhibitors |
Mechanism HBV capsid inhibitors(HBV capsid inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Viremia | Phase 2 | China | 14 Nov 2024 | |
| Hepatitis B, Chronic | Phase 2 | China | 25 Sep 2024 |
Phase 2 | 122 | TQA3605+NAs | xbrolrqfmx(dgpmkzmltq) = dkxfxkstzz hmygkgdvqk (sdxeyisgae ) Met View more | Positive | 27 Jan 2026 | ||
placebo+NAs | zjyvtqzvzf(owltzgprgz) = ymyigzmkqc uzpmvaapwy (qonlsgbtpo ) |





